{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:18:38Z","timestamp":1787159918787,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006191","name":"Eskisehir Osmangazi University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006191","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Despite therapeutic advances such as biologics and small-molecule inhibitors, narrowband ultraviolet B (NB-UVB) phototherapy remains essential in dermatology. In recent years, the elderly population has been increasing worldwide, so NB-UVB will be more crucial in geriatric dermatology. In this study, we aimed to evaluate the efficacy and safety of NB-UVB in various dermatoses seen in elderly patients. This observational, retrospective study included patients over 65 who received NB-UVB for any dermatological disease between 2014 and 2024. We retrospectively reviewed the phototherapy and clinical follow-up forms of the patients. A total of 126 patients were included in this study. Fifty-two (41.3%) patients were male and 74 (58.7%) were female. The mean age of the patients was 71.9\u2009\u00b1\u20096.90\u00a0years. NB-UVB was administered most frequently to 30 (23.8%) of the patients with the diagnosis of generalized pruritus, 23 (18.3%) with mycosis fungoides, 20 (15.9%) with psoriasis, 15 (11.9%) with lichen planus, and 14 (11.1%) with prurigo nodularis. The mean number of sessions was 47.7\u2009\u00b1\u200921.4, and the cumulative UVB dose was 73.17\u2009\u00b1\u200949.87\u00a0J\/cm\n                    <jats:sup>2<\/jats:sup>\n                    in all patients. 68 (%54) patients achieved complete response, and 46 (%36.5) patients achieved partial response. Mild side effects were observed in 23 (18.3%) patients. None of them led to discontinuation of treatment. Antinuclear antibody (ANA) was positive in 29.4% of the patients. There was no statistically significant difference between ANA positivity and side effect development (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.644). NB-UVB is an effective and safe treatment option for dermatoses such as generalized pruritus, mycosis fungoides, psoriasis, lichen planus, prurigo nodularis in the elderly population,\n                  <\/jats:p>","DOI":"10.1007\/s10103-026-04850-3","type":"journal-article","created":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:51:47Z","timestamp":1773298307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Narrowband ultraviolet B phototherapy for dermatoses seen in elderly: a real-life experience"],"prefix":"10.1007","volume":"41","author":[{"given":"Ersoy","family":"Acer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"A\u011fao\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hi\u0307lal","family":"Kaya Erdo\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hi\u0307laL","family":"\u00c7avu\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belgi\u0307n","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Bi\u0307lgi\u0307n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep Nurhan","family":"Sara\u00e7o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"4850_CR1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.det.2014.03.003","volume":"32","author":"MB Totonchy","year":"2014","unstructured":"Totonchy MB, Chiu MW (2014) UV-based therapy. Dermatol Clin 32:399\u2013413","journal-title":"Dermatol Clin"},{"key":"4850_CR2","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1080\/09546634.2021.2019660","volume":"33","author":"A Oulee","year":"2022","unstructured":"Oulee A, Javadi SS, Martin A, Do T, Wu JJ (2022) Phototherapy trends in dermatology 2015\u20132018. J Dermatolog Treat 33:2545\u20132546","journal-title":"J Dermatolog Treat"},{"key":"4850_CR3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaad.2020.04.095","volume":"84","author":"AE Torres","year":"2021","unstructured":"Torres AE, Lyons AB, Hamzavi IH, Lim HW (2021) Role of phototherapy in the era of biologics. J Am Acad Dermatol 84:479\u2013485","journal-title":"J Am Acad Dermatol"},{"key":"4850_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.jaad.2018.03.018","volume":"79","author":"SY Tan","year":"2018","unstructured":"Tan SY, Buzney E, Mostaghimi A (2018) Trends in phototherapy utilization among Medicare beneficiaries in the United States, 2000 to 2015. J Am Acad Dermatol 79:672\u2013679","journal-title":"J Am Acad Dermatol"},{"key":"4850_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/phpp.12683","volume":"37","author":"TA Merkel","year":"2021","unstructured":"Merkel TA, Navarini A, Mueller S (2021) Differences in phototherapy among skin diseases and genders in real-life conditions-a retrospective analysis of the cumulative doses, numbers of sessions, side effects and costs in 561 patients. Photodermatol Photoimmunol Photomed 37:464\u2013473","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"4850_CR6","unstructured":"Tuik.gov.tr . Elderly with statistics. Turkey: Turkish Statistical Institute 2023. Ankara Medical Journal 24.4 (2024). Available from: https:\/\/data.tuik.gov.tr\/Bulten\/Index?p=Istatistiklerle-Yaslilar-2023-"},{"key":"4850_CR7","doi-asserted-by":"publisher","first-page":"521.e1","DOI":"10.1016\/j.jaad.2012.10.063","volume":"68","author":"JO Endo","year":"2013","unstructured":"Endo JO, Wong JW, Norman RA, Chang ALS (2013) Geriatric dermatology: part I. Geriatric pharmacology for the dermatologist. J Am Acad Dermatol 68:521.e1-521.e10","journal-title":"J Am Acad Dermatol"},{"key":"4850_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1590\/abd1806-4841.20185468","volume":"93","author":"I Bulur","year":"2018","unstructured":"Bulur I, Erdogan HK, Aksu AE, Karap\u0131nar T, Saracoglu ZN (2018) The efficacy and safety of phototherapy in geriatric patients: a retrospective study. An Bras Dermatol 93:33\u201338","journal-title":"An Bras Dermatol"},{"key":"4850_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/ced.12626","volume":"40","author":"JB Powell","year":"2015","unstructured":"Powell JB, Gach JE (2015) Phototherapy in the elderly. Clin Exp Dermatol 40:605\u2013610","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"4850_CR10","doi-asserted-by":"publisher","first-page":"e2022145","DOI":"10.5826\/dpc.1203a145","volume":"12","author":"G Aksoy Sarac","year":"2022","unstructured":"Aksoy Sarac G, Emeksiz MAC, Acar O, Nazlican E, Tanacan E, Nayir T (2022) Retrospective analysis of dermatological diseases in geriatric patients during dermatology outpatient department visits. Dermatol Pract Concept 12(3):e2022145","journal-title":"Dermatol Pract Concept"},{"key":"4850_CR11","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-4632.2005.02607.x","volume":"45","author":"B Yal\u00e7in","year":"2006","unstructured":"Yal\u00e7in B, Tamer E, Toy GG, Ozta\u015f P, Hayran M, Alli N (2006) The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol 45:672\u2013676","journal-title":"Int J Dermatol"},{"key":"4850_CR12","volume":"13","author":"E Myers","year":"2021","unstructured":"Myers E, Kheradmand S, Miller R (2021) An update on narrowband ultraviolet B therapy for the treatment of skin diseases. Cureus 13:e19182","journal-title":"Cureus"},{"key":"4850_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2340\/00015555-2574","volume":"97","author":"CJ Clerc","year":"2017","unstructured":"Clerc CJ, Misery L (2017) A literature review of senile pruritus: from diagnosis to treatment. Acta Derm Venereol 97:433\u2013440","journal-title":"Acta Derm Venereol"},{"key":"4850_CR14","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cger.2023.09.010","volume":"40","author":"S Meltan","year":"2024","unstructured":"Meltan S, Panuganti B, Tarbox M (2024) Evaluation and management of pruritus and scabies in the elderly population. Clin Geriatr Med 40:91\u2013116","journal-title":"Clin Geriatr Med"},{"issue":"22","key":"4850_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010174","volume":"26","author":"BY Chung","year":"2020","unstructured":"Chung BY, Um JY, Kim JC, Kang SY, Park CW, Kim HO (2020) Pathophysiology and treatment of pruritus in elderly. Int J Mol Sci 26(22):174","journal-title":"Int J Mol Sci"},{"key":"4850_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2004.12.052","volume":"53","author":"S Ada","year":"2005","unstructured":"Ada S, Se\u00e7kin D, Budako\u011flu I, Ozdemir FN (2005) Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study. J Am Acad Dermatol 53:149\u2013151","journal-title":"J Am Acad Dermatol"},{"key":"4850_CR17","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1468-3083.2006.01635.x","volume":"20","author":"G G\u00f6kdemir","year":"2006","unstructured":"G\u00f6kdemir G, Barutcuoglu B, Sakiz D, K\u00f6\u015fl\u00fc A (2006) Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes. J Eur Acad Dermatol Venereol 20:804\u2013809","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4850_CR18","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/phpp.12873","volume":"39","author":"C Zengarini","year":"2023","unstructured":"Zengarini C, Baruffaldi G, Piraccini BM et al (2023) Nb-UVB and PUVA therapy in treating early stages of Mycosis Fungoides: a single-center cross-sectional study. Photodermatol Photoimmunol Photomed 39:435\u2013440","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"4850_CR19","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/j.1365-2230.2005.01840.x","volume":"30","author":"SZ Ghodsi","year":"2005","unstructured":"Ghodsi SZ, Hallaji Z, Balighi K, Safar F, Chams-Davatchi C (2005) Narrow-band UVB in the treatment of early stage mycosis fungoides: report of 16 patients. Clin Exp Dermatol 30:376\u2013378","journal-title":"Clin Exp Dermatol"},{"key":"4850_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2340\/00015555-0283","volume":"87","author":"K Ahmad","year":"2007","unstructured":"Ahmad K, Rogers S, McNicholas PD, Collins P (2007) Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study. Acta Derm Venereol 87:413\u2013417","journal-title":"Acta Derm Venereol"},{"key":"4850_CR21","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.clindermatol.2017.10.013","volume":"36","author":"K Kostovi\u0107","year":"2018","unstructured":"Kostovi\u0107 K, \u017du\u017eul K, \u010ceovi\u0107 R, Bukvi\u0107 Mokos Z (2018) Psoriasis in the mature patient: therapeutic approach in the era of biologics. Clin Dermatol 36:222\u2013230","journal-title":"Clin Dermatol"},{"key":"4850_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-4632.2011.04979.x","volume":"51","author":"HH Kwon","year":"2012","unstructured":"Kwon HH, Kwon IH, Youn JI (2012) Clinical study of psoriasis occurring over the age of 60 years: is elderly-onset psoriasis a distinct subtype? Int J Dermatol 51:53\u201358","journal-title":"Int J Dermatol"},{"key":"4850_CR23","doi-asserted-by":"crossref","unstructured":"Grozdev IS, Van Voorhees AS, Gottlieb AB, Hsu S, Lebwohl MG, Bebo BF Jr, Korman NJ (2011) National psoriasis foundation. Psoriasis in the elderly: from the medical board of the national psoriasis foundation. J Am Acad Dermatol 65:537\u2013545","DOI":"10.1016\/j.jaad.2010.05.014"},{"key":"4850_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s40266-014-0156-6","volume":"31","author":"N Balato","year":"2014","unstructured":"Balato N, Patruno C, Napolitano M, Patr\u00ec A, Ayala F, Scarpa R (2014) Managing moderate-to-severe psoriasis in the elderly. Drugs Aging 31:233\u2013238","journal-title":"Drugs Aging"},{"key":"4850_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0181813","volume":"12","author":"J Foerster","year":"2017","unstructured":"Foerster J, Boswell K, West J et al (2017) Narrowband UVB treatment is highly effective and causes a strong reduction in the use of steroid and other creams in psoriasis patients in clinical practice. PLoS One 12:e0181813","journal-title":"PLoS One"},{"key":"4850_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/dth.15283","volume":"35","author":"R Diab","year":"2022","unstructured":"Diab R, Araghi F, Gheisari M, Kani ZA, Moravvej H (2022) Lichen planus and lichen planopilaris flare after COVID-19 vaccination. Dermatol Ther 35:e15283","journal-title":"Dermatol Ther"},{"key":"4850_CR27","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1111\/jdv.16464","volume":"34","author":"D Ioannides","year":"2020","unstructured":"Ioannides D, Vakirlis E, Kemeny L et al (2020) European S1 guidelines on the management of lichen planus: a cooperation of the European dermatology forum with the European academy of dermatology and venereology. J Eur Acad Dermatol Venereol 34:1403\u20131414","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4850_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/phpp.12723","volume":"38","author":"B Weber","year":"2022","unstructured":"Weber B, Marquart E, Radakovic S, Tanew A (2022) Effectiveness of narrowband UVB phototherapy and psoralen plus UVA photochemotherapy in the treatment of generalized lichen planus: results from a large retrospective analysis and an update of the literature. Photodermatol Photoimmunol Photomed 38:104\u2013111","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"4850_CR29","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.jaad.2020.04.182","volume":"83","author":"KA Williams","year":"2020","unstructured":"Williams KA, Huang AH, Belzberg M, Kwatra SG (2020) Prurigo nodularis: pathogenesis and management. J Am Acad Dermatol 83:1567\u20131575","journal-title":"J Am Acad Dermatol"},{"key":"4850_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ad.2020.11.007","volume":"112","author":"A Arrieta","year":"2021","unstructured":"Arrieta A, Jaka A, Del Alc\u00e1zar E, Blanco M, Carrascosa JM (2021) Phototherapy for prurigo nodularis: our experience and a review of the literature. Actas Dermosifiliogr (Engl Ed) 112:339\u2013344","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"24","key":"4850_CR31","first-page":"00193","volume":"S0365\u20130596","author":"E Agaoglu","year":"2024","unstructured":"Agaoglu E, Kaya Erdogan H, Acer E, Saracoglu ZN (2024) Efficacy and safety of narrowband ultraviolet B phototherapy for prurigo nodularis: a tertiary center experience. An Bras Dermatol S0365\u20130596(24):00193\u201300194","journal-title":"An Bras Dermatol"},{"key":"4850_CR32","first-page":"882","volume":"21","author":"B Kurz","year":"2023","unstructured":"Kurz B, Berneburg M, B\u00e4umler W, Karrer S (2023) Phototherapy: theory and practice. J Dtsch Dermatol Ges 21:882\u2013897","journal-title":"J Dtsch Dermatol Ges"},{"key":"4850_CR33","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaad.2022.05.012","volume":"88","author":"S Ramadan","year":"2023","unstructured":"Ramadan S, Zeid OA, Esmat S, Saleh NA, Assaf M, Hilal RF (2023) Combination of acitretin and narrowband UV-B for the treatment of vitiligo: a new treatment modality with an impact on tissue E-cadherin expression. J Am Acad Dermatol 88:241\u2013243","journal-title":"J Am Acad Dermatol"},{"key":"4850_CR34","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1111\/phpp.12601","volume":"36","author":"O Kutlu","year":"2020","unstructured":"Kutlu O, Ozdemir Cetinkaya P, Karaosmanoglu N et al (2020) The effect of narrowband ultraviolet B phototherapy on antinuclear antibody status: a case-control study. Photodermatol Photoimmunol Photomed 36:470\u2013475","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"4850_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/phpp.12559","volume":"36","author":"C Chaiyabutr","year":"2020","unstructured":"Chaiyabutr C, Wongpraparut C, Charoenpipatsin N, Pruksaeakanan C, Silpa-Archa N (2020) The necessity of antinuclear antibody investigation in pre-phototherapy vitiligo patients: a retrospective study. Photodermatol Photoimmunol Photomed 36:373\u2013377","journal-title":"Photodermatol Photoimmunol Photomed"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04850-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-026-04850-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-026-04850-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:52:45Z","timestamp":1781639565000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-026-04850-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4850"],"URL":"https:\/\/doi.org\/10.1007\/s10103-026-04850-3","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Participate declaration"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}}],"article-number":"52"}}